References
- Duca B, Patel N, Turner PJ. GRADE-ing the benefit/risk equation in food immunotherapy. Curr Allergy Asthma Rep. 2019;19(6):30.
- Chinthrajah RS, Purington N, Andorf S, et al. Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study. Lancet. 2019;394(10207):1437–1449.
- FDA approves first drug for treatment of peanut allergy for children. Cited 2020 Jan 31. Available from: https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-treatment-peanut-allergy-children Cited 2021 Dec 24
- Committee for Medicinal Products for Human Use (CHMP), European medicines agency. Cited 2020 Oct 15. Available from: https://www.ema.europa.eu/en/documents/assessment-report/palforzia-epar-public-assessment-report_en.pdf Cited 2021 Dec 24
- Wasserman RL, Hague AR, Pence DM, et al. Real-world experience with peanut oral immunotherapy: lessons learned from 270 patients. J Allergy Clin Immunol Pract. 2019;7(2):418–426.e4.
- Vazquez-Ortiz M, Turner PJ. Improving the safety of oral immunotherapy for food allergy. Pediatr Allergy Immunol. 2016;27(2):117–125.
- Ontario mother warns of allergy therapy risks after daughter’s death. Available from: https://www.ctvnews.ca/health/it-seems-unbelievable-ont-mother-warns-of-allergy-therapy-risks-after-daughter-s-death-1.5716985 Cited 2021 December 24
- Wüthrich B. History of food allergy. Chem Immunol Allergy. 2014;100:109–119.
- Maimonides M. Treatise on asthma. Muntner S, editor. Philadelphia: Lippincott; 1963. p. 2.
- Directive 2000/13/EC of The European Parliament and of The Council. Available from: https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CONSLEG:2000L0013:20090120:EN:PDF Cited 2021 Dec 24
- US Food and Drug Administration. Food Allergen Labeling and Consumer Protection Act of 2004 (FALCPA). Available from: https://www.fda.gov/food/food-allergensgluten-free-guidance-documents-regulatory-information/food-allergen-labeling-and-consumer-protection-act-2004-falcpa Cited 2021 December 24)
- Schofield AT. A case of egg poisoning. Lancet. 1908;171:716.
- Patriarca G, Schiavino D, Nucera E, et al. Food allergy in children: results of a standardized protocol for oral desensitization. Hepatogastroenterology. 1998;45(19):52–58.
- Morisset M, Moneret-Vautrin DA, Guenard L, et al. Oral desensitization in children with milk and egg allergies obtains recovery in a significant proportion of cases. A randomized study in 60 children with cow’s milk allergy and 90 children with egg allergy. Eur Ann Allergy Clin Immunol. 2007;39(1):12–19.
- Nelson HS, Lahr J, Rule R, et al. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol. 1997;99(6 Pt 1):744–751.
- Martorell A, Alonso E, Echeverría L, et al.; Expert panel selected from members of the Spanish Society of Pediatric Allergology, Asthma and Clinical Immunology (SEICAP) and the Spanish Society of Allergology and Clinical Immunology (SEAIC). Oral immunotherapy for food allergy: a Spanish guideline. immunotherapy egg and milk spanish guide (ITEMS guide). Part I: cow milk and egg oral immunotherapy: introduction, methodology, rationale, current state, indications, contraindications, and oral immunotherapy build-up phase. J Investig Allergol Clin Immunol. 2017;27(4):225–237.
- Ebisawa M, Ito K, Fujisawa T. Committee for Japanese pediatric guideline for food allergy, The Japanese Society of Pediatric Allergy and Clinical Immunology; Japanese Society of Allergology. Japanese guidelines for food allergy 2020. Allergol Int. 2020;69(3):370–386.
- Muraro A, Werfel T, Hoffmann-Sommergruber K, et al.; EAACI Food Allergy and Anaphylaxis Guidelines Group. EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy. 2014;69(8):1008–1025.
- Pajno GB, Fernandez-Rivas M, Arasi S, et al.; EAACI Allergen Immunotherapy Guidelines Group. EAACI guidelines on allergen immunotherapy: IgE-mediated food allergy. Allergy. 2018;73(4):799–815.
- Bégin P, Chan ES, Kim H, et al. CSACI guidelines for the ethical, evidence-based and patient-oriented clinical practice of oral immunotherapy in IgE-mediated food allergy. Allergy Asthma Clin Immunol. 2020;16:20.
- Calvani M, Giorgio V, Miceli Sopo S. Specific oral tolerance induction for food. A systematic review. Eur Ann Allergy Clin Immunol. 2010;42(1):11–19.
- Nurmatov U, Venderbosch I, Devereux G, et al. Allergen-specific oral immunotherapy for peanut allergy. Cochrane Database Syst Rev. 2012;9:CD009014. DOI:https://doi.org/10.1002/14651858.CD009014.pub2
- Yeung JP, Kloda LA, McDevitt J, et al. Oral immunotherapy for milk allergy. Cochrane Database Syst Rev. 2012;11(11):CD009542.
- Romantsik O, Bruschettini M, Tosca MA, et al. Oral and sublingual immunotherapy for egg allergy. Cochrane Database Syst Rev. 2014;11:CD010638. DOI:https://doi.org/10.1002/14651858.CD010638.pub2
- Nurmatov U, Devereux G, Worth A, et al. Effectiveness and safety of orally administered immunotherapy for food allergies: a systematic review and meta-analysis. Br J Nutr. 2014;111(1):12–22.
- Nurmatov U, Dhami S, Arasi S, et al. Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis. Allergy. 2017;72(8):1133–1147.
- de Silva D, Rodríguez Del Río P, de Jong NW, et al.; GA2LEN Food Allergy Guidelines Group. Allergen immunotherapy and/or biologicals for IgE-mediated food allergy: a systematic review and meta-analysis. Allergy. 2022. doi:https://doi.org/10.1111/all.15211.
- National Institute for Health and Care Excellence. Single technology appraisal of palforzia for treating peanut allergy. Cited 2021 Dec 23. Available from: https://www.nice.org.uk/guidance/indevelopment/gid-ta10713 Cited 2021 Dec 24
- Venter C, Meyer R, Ebisawa M, et al. Food allergen ladders: a need for standardization. Pediatr Allergy Immunol. 2022;33(1):e13714.
- Ball HB, Luyt D. Home-based cow’s milk reintroduction using a milk ladder in children less than 3 years old with IgE-mediated cow’s milk allergy. Clin Exp Allergy. 2019;49(6):911–920.
- MacMahon J, Hourihane JO, Byrne A. A virtual management approach to infant egg allergy developed in response to pandemic-imposed restrictions. Clin Exp Allergy. 2021;51(2):360–363.
- Chomyn A, Chan ES, Yeung J, et al. Canadian food ladders for dietary advancement in children with IgE-mediated allergy to milk and/or egg. Allergy Asthma Clin Immunol. 2021;17(1):83.
- Turner PJ, Gowland MH, Sharma V, et al. Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992-2012. J Allergy Clin Immunol. 2015;135(4):956–963.e1.
- Baseggio Conrado A, Ierodiakonou D, Gowland MH, et al. Food anaphylaxis in the United Kingdom: analysis of national data, 1998-2018. BMJ. 2021;372:n251.
- Leonard SA. Debates in allergy medicine: baked milk and egg ingestion accelerates resolution of milk and egg allergy. World Allergy Organ J. 2016;9:1.
- Dang TD, Peters RL, Allen KJ. Debates in allergy medicine: baked egg and milk do not accelerate tolerance to egg and milk. World Allergy Organ J. 2016;9:2.
- Remington BC, Westerhout J, Campbell DE, et al. Minimal impact of extensive heating of hen’s egg and cow’s milk in a food matrix on threshold dose-distribution curves. Allergy. 2017;72(11):1816–1819.
- BSACI and The Canadian Society of Allergy and Clinical Immunology joint statement on oral immunotherapy. Available from: https://www.bsaci.org/bsaci-and-the-canadian-society-of-allergy-and-clinical-immunology-joint-statement-on-oral-immunotherapy/. Cited 2022 Feb 18.
- Yonkof JR, Mikhail IJ, Prince BT, et al. Delayed and severe reactions to baked egg and baked milk challenges. J Allergy Clin Immunol Pract. 2021;9(1):283–289.e2.
- Rodríguez Del Río P, Escudero C, Sánchez-García S, et al. Evaluating primary end points in peanut immunotherapy clinical trials. J Allergy Clin Immunol. 2018;143(2):494–506.
- Peanut curry death: Mohammed Zaman fails in appeal Bid. Available from: https://www.bbc.co.uk/news/uk-england-york-north-yorkshire-41926399 Cited 2021 Dec 24.
- Dua S, Ruiz-Garcia M, Bond S, et al. Effect of sleep deprivation and exercise on reaction threshold in adults with peanut allergy: a randomized controlled study. J Allergy Clin Immunol. 2019;144(6):1584–1594.e2.
- Patel N, Adelman DC, Anagnostou K, et al. Using data from food challenges to inform management of consumers with food allergy: a systematic review with individual participant data meta-analysis. J Allergy Clin Immunol. 2021;147(6):2249–2262.e7.
- Turner PJ, Baumert JL, Beyer K, et al. Can we identify patients at risk of life-threatening allergic reactions to food? Allergy. 2016;71(9):1241–1255.
- Anagnostou K, Clark A, King Y, et al. Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcome. Clin Exp Allergy. 2011;41(9):1273–1281.
- Furuta T, Tanaka K, Tagami K, et al. Exercise-induced allergic reactions on desensitization to wheat after rush oral immunotherapy. Allergy. 2020;75(6):1414–1422.
- Anagnostou K, Islam S, King Y, et al. Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial. Lancet. 2014;383(9925):1297–1304.
- Chu DK, Wood RA, French S, et al. Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety. Lancet. 2019;393(10187):2222–2232.
- Tice JA, Guzauskas GF, Hansen RN, et al. The effectiveness and value of oral immunotherapy and viaskin peanut for peanut allergy. J Manag Care Spec Pharm. 2020;26(5):620–623.
- Burrell S, Patel N, Vazquez-Ortiz M, et al. Self-administration of Adrenaline for anaphylaxis during in-hospital food challenges improves health-related quality of life. Arch Dis Child. 2021;106(6):558–563.
- European Academy of Allergy. Clinical immunology clinical outcomes in food-AIT trials Harmonization (CO-FAITH) taskforce. Available from: https://www.eaaci.org/science/task-forces.html Cited 2021 Dec 24
- PALISADE Group of Clinical Investigators. AR101 oral immunotherapy for peanut allergy. N Engl J Med. 2018;379(21): 1991–2001.
- O’B Hourihane J, Beyer K, Abbas A, et al. Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial. Lancet Child Adolesc Health. 2020;4(10):728–739.
- Institute for Clinical and Economic Review (ICER). Oral immunotherapy and Viaskin® peanut for peanut allergy: effectiveness and value. Available from: https://icer.org/wp-content/uploads/2020/10/ICER_PeanutAllergy_Final_Report_071019.pdf Cited 2021 Dec 24
- Shaker M, Greenhawt M. Estimation of health and economic benefits of commercial peanut immunotherapy products: a cost-effectiveness analysis. JAMA Network Open. 2019;2(5):e193242.
- Patel N, Lindsley S, Vazquez-Ortiz M, et al. Significant impact of screening challenge on the improvement in health-related quality of life during oral immunotherapy (OIT). J Allergy Clin Immunol. 2020;145(2):AB135.
- DunnGalvin A, Cullinane C, Daly DA, et al. Longitudinal validity and responsiveness of the Food Allergy Quality of Life Questionnaire - Parent Form in children 0-12 years following positive and negative food challenges. Clin Exp Allergy. 2010;40:476–485.
- Soller L, Hourihane J, DunnGalvin A. The impact of oral food challenge tests on food allergy health-related quality of life. Allergy. 2014;69:1255–1257.
- Shaker MS. An economic analysis of a peanut oral immunotherapy study in children. J Allergy Clin Immunol Pract. 2017;5(6):1707–1716.
- Shaker M, Chan ES, Protudjer JLP, et al. The cost-effectiveness of preschool peanut oral immunotherapy in the real-world setting. J Allergy Clin Immunol Pract. 2021;9(7):2876–2884.e4.
- Fiocchi A, Artesani MC, Fierro V, et al. Oral immunotherapy for peanut allergy: the con argument. World Allergy Organ J. 2020;13(8):100445.
- Vazquez-Ortiz M, Alvaro-Lozano M, Alsina L, et al. Safety and predictors of adverse events during oral immunotherapy for milk allergy: severity of reaction at oral challenge, specific IgE and prick test. Clin Exp Allergy. 2013;43:92–102.
- Savilahti EM, Kuitunen M, Valori M, et al. Use of IgE and IgG4 epitope binding to predict the outcome of oral immunotherapy in cow’s milk allergy. Pediatr Allergy Immunol. 2014;25:227–235.
- Vazquez-Ortiz M, Alvaro M, Piquer M, et al. Baseline specific IgE levels are useful to predict safety of oral immunotherapy in egg allergic children. Clin Exp Allergy. 2014;44:130–141.
- Vickery BP, Berglund JP, Burk CM, et al. Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective. J Allergy Clin Immunol. 2017;139(1):173–181.e8.
- Jones SM, Kim EH, Nadeau KC, et al.; Immune Tolerance Network. Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study. Lancet. 2022;399(10322):359–371.
- Rasbach L, Jenkins C, Laffel L. An integrative review of self-efficacy measurement instruments in youth with type 1 diabetes. Diabetes Educ. 2015;41(1):43–58.
- UK Government. Natasha’s legacy becomes law. Cited 2019 Sept 5. Available from: https://www.gov.uk/government/news/natashas-legacy-becomes-law Cited 2021 Dec 24
- US Congress. Food Allergy Safety, Treatment, Education, and Research (FASTER) act of 2020. Available from: https://www.congress.gov/bill/116th-congress/house-bill/2117/text Cited 2021 Dec 24)
- US Congress. School access to emergency epinephrine act. Cited 2013 Sept 12. Available from: https://www.congress.gov/bill/113th-congress/senate-bill/1503 Cited 2021 Dec 24
- UK Government. The human medicines (amendment) regulations 2017. Available from: https://www.legislation.gov.uk/uksi/2017/715/made Cited 2021 Dec 24
- Wasserman RL, Hague AR, Pence DM, et al. The real world is not standardized. J Allergy Clin Immunol Pract. 2019;7(6):2098–2099.
- Perkin MR. Oral desensitization to peanuts. N Engl J Med. 2018;379(21):2074–2075.
- World Economic Forum. The Global Risks Report 2020. Available from: https://www.weforum.org/reports/the-global-risks-report-2020 Cited 2021 Dec 24
- Turner PJ, Jerschow E, Umasunthar T, et al. Fatal anaphylaxis: mortality rate and risk factors. J Allergy Clin Immunol Pract. 2017;5(5):1169–1178.
- Turner PJ, Andoh-Kesson E, Baker S, et al. Identifying key priorities for research to protect the consumer with food hypersensitivity: a UK Food Standards Agency Priority Setting Exercise. Clin Exp Allergy. 2021;51(10):1322–1330.
- Turner PJ. Persistent allergy to cow’s milk: of greater a clinical concern than other food allergies. Pediatr Allergy Immunol. 2013;24:624–626.
- Barnett J, Begen FM, Gowland MH, et al. Comparing the eating out experiences of consumers seeking to avoid different food allergens. BMC Public Health. 2018;18:1263.
- Warren CM, Turner PJ, Chinthrajah RS, et al. Advancing food allergy through epidemiology: understanding and addressing disparities in food allergy management and outcomes. J Allergy Clin Immunol Pract. 2021;9(1):110–118.
- Allen KJ, Turner PJ, Pawankar R, et al. Precautionary labelling of foods for allergen content: are we ready for a global framework? World Allergy Organ J. 2014;7(1):10.
- Pouessel G, Beaudouin E, Tanno LK, et al.; Allergy Vigilance Network®. Food-related anaphylaxis fatalities: analysis of the Allergy Vigilance Network® database. Allergy. 2019;74(6):1193–1196.
- Abrams EM, Erdle SC, Cameron SB, et al. How to incorporate oral immunotherapy into your clinical practice. Curr Allergy Asthma Rep. 2021;21(4):30.
- Baseggio Conrado A, Patel N, Turner PJ. Global patterns in anaphylaxis due to specific foods: a systematic review. J Allergy Clin Immunol. 2021;148(6):1515–1525.e3.
- Anagnostou A, Hourihane JO, Greenhawt M. The role of shared decision making in pediatric food allergy management. J Allergy Clin Immunol Pract. 2020;8(1):46–51.
- Graham F, Mack DP, Bégin P. Practical challenges in oral immunotherapy resolved through patient-centered care. Allergy Asthma Clin Immunol. 2021;17(1):31.